Market intelligence
All coverage
Regular U.S. trading is still ahead, making Tuesday’s close the reference point for now. Wolfspeed ended the session at $53.72, a gain of 6.8%,…
Ouster shares climbed ahead of Wednesday’s bell, buoyed by news that its latest Rev8 OS digital lidar sensors secured qualification for NVIDIA DRIVE Hyperion—a…
Nvidia heads into Wednesday’s U.S. session with investors zeroed in on a single issue: will China actually deliver fresh revenue, or is this just…
Stocks took a step back in after-hours trading Tuesday, giving up some of the day’s gains as investors trimmed positions in top AI names.…
Karman Holdings Inc. posted first-quarter numbers and bumped its 2026 outlook. The initial move? Shares climbed 6.22% to close at $62.48. But the print…
Velo3D shares reversed sharply in after-hours action Tuesday. The stock ended the session at $14.06, but after the company reported first-quarter results, it jumped…
Penguin Solutions was anything but subdued. The stock wrapped Nasdaq trading at $44.13, a 1.36% gain, after swinging from $39.72 up to $44.71 on…
Rackspace Technology didn’t just tack on more gains to last week’s surge—it blew right past it, triggering a sharp repricing in the process. Shares…
OpenEvidence has teamed up with the Society of Surgical Oncology, moving to integrate the group’s surgical cancer-care resources into its medical AI platform. The…
Tuesday split into two acts for Nextpower shares. They slipped 0.70% to close at $125.37 in the regular session. But after the company posted…
United Airlines flight attendants have signed off on a fresh five-year contract, securing an average 31% bump to base pay, new boarding pay, and…
Oklo posted a first-quarter net loss of $33.1 million, or 19 cents per share, blowing past last year’s $9.8 million, or 7 cents. The…
QuantumScape shares climbed Tuesday after the company reported its Eagle Line pilot ramp-up and logged its initial $11.0 million in quarterly customer billings—modest, but…
Shares of SELLAS Life Sciences climbed in after-hours action Tuesday, following the company’s update that its Phase 3 REGAL trial in acute myeloid leukemia…
British American Tobacco didn’t jump on earnings news this time. Instead, shares surged as investors caught a break on both U.S. nicotine regulation and…
Camtek Ltd. shares tumbled 15.8%, not because Q1 was soft—just not up to the price tag. The company edged past estimates, topping adjusted EPS…
